The main aim of NEURONET is to set up an efficient platform to boost synergy and collaboration across the Innovative Medicines Initiative projects of the neurodegenerative disorders portfolio, assisting in identifying gaps, multiplying its impact, enhancing its visibility and facilitating dovetailing with related initiatives in Europe and worldwide.